Insurance Post

Endurance slams 'entrenched' Aspen board after 'poison pill' rights plan

Concept image of people merger

In a letter to shareholders dated April 20, Glyn Jones chairman of Aspen's board of directors and Aspen's chief executive officer Chris O'Kane reiterated their stance that Endurance's unsolicited bid

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected]ne.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: